Unknown

Dataset Information

0

MTOR controls ChREBP transcriptional activity and pancreatic ? cell survival under diabetic stress.


ABSTRACT: Impaired nutrient sensing and dysregulated glucose homeostasis are common in diabetes. However, how nutrient-sensitive signaling components control glucose homeostasis and ? cell survival under diabetic stress is not well understood. Here, we show that mice lacking the core nutrient-sensitive signaling component mammalian target of rapamycin (mTOR) in ? cells exhibit reduced ? cell mass and smaller islets. mTOR deficiency leads to a severe reduction in ? cell survival and increased mitochondrial oxidative stress in chemical-induced diabetes. Mechanistically, we find that mTOR associates with the carbohydrate-response element-binding protein (ChREBP)-Max-like protein complex and inhibits its transcriptional activity, leading to decreased expression of thioredoxin-interacting protein (TXNIP), a potent inducer of ? cell death and oxidative stress. Consistent with this, the levels of TXNIP and ChREBP were highly elevated in human diabetic islets and mTOR-deficient mouse islets. Thus, our results suggest that a nutrient-sensitive mTOR-regulated transcriptional network could be a novel target to improve ? cell survival and glucose homeostasis in diabetes.

SUBMITTER: Chau GC 

PROVIDER: S-EPMC5496625 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.

Chau Gia Cac GC   Im Dong Uk DU   Kang Tong Mook TM   Bae Jeong Mo JM   Kim Won W   Pyo Suhkneung S   Moon Eun-Yi EY   Um Sung Hee SH  

The Journal of cell biology 20170612 7


Impaired nutrient sensing and dysregulated glucose homeostasis are common in diabetes. However, how nutrient-sensitive signaling components control glucose homeostasis and β cell survival under diabetic stress is not well understood. Here, we show that mice lacking the core nutrient-sensitive signaling component mammalian target of rapamycin (mTOR) in β cells exhibit reduced β cell mass and smaller islets. mTOR deficiency leads to a severe reduction in β cell survival and increased mitochondrial  ...[more]

Similar Datasets

| S-EPMC2744847 | biostudies-literature
| S-EPMC3402328 | biostudies-literature
| S-EPMC2519732 | biostudies-literature
| S-EPMC2780802 | biostudies-literature
| S-EPMC5123192 | biostudies-literature
| S-EPMC2527113 | biostudies-literature
| S-EPMC6938857 | biostudies-literature
| S-EPMC11362803 | biostudies-literature
2023-02-07 | GSE173267 | GEO